Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Total Reportable Segments by Year
Total Reportable Segments — Adjusted Operating Gain (Non-GAAP) ($M)
Elevance Health Total Reportable Segments: $7,462M in FY2025, down 20.0% from a year earlier.
Latest, FY2025
7,462
Period ended Dec 31, 2025
Change on a year earlier
-20.0%
9,327 in FY2024
History
4 years
Since FY2022
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| Reportable segments adjusted operating gain | $ | 375 | $ | 841 | (55.4 | %) | $ | 7,462 | $ | 9,327 | (20.0 | %)”
Source: 8-K ER (FY2025Q4, 2026-01-28) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Reportable Segments — Adjusted Operating Gain (Non-GAAP) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,462 | -20.0% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2024 | Dec 31, 2024 | 9,327 | -1.1% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2023 | Dec 31, 2023 | 9,429 | +12.8% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| FY2022 | Dec 31, 2022 | 8,362 | – | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
Cite this data
StockData. (2026). Elevance Health Total Reportable Segments ($M), annual FY2022–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-op-gain-adjusted-total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.